You are here
Lie-Ju has worked for Pfizer since May 2001. She has been recognized as an effective statistical leader in multiple disease areas including Neuroscience, Pain and Inflammation, Ophthalmology, and Pulmonary Vascular Disease. She has presented abstracts/posters at major congresses at both national and international levels.
Lie-Ju has extensive knowledge in clinical development processes and data mining experiences. She has used her strategic and analytical thinking, in collaboration with both the internal Pfizer clinical team and the external medical community, to design clinical trials and manage Phase II-IV clinical trials effectively. She is also a key contributor to scientific journals.
The U.S. Centers for Disease Control and Prevention (CDC) works alongside China's Ministry of Health to address emerging infectious diseases in China including supporting disease surveillance and detection programs as a means to improve outbreak response. Pfizer Global Health Fellows will conduct epidemiological studies and work with research staff in eight high priority hospitals in China to improve techniques in collecting and analyzing pneumococcal specimens. Lie-Ju hopes her Fellowship experience will help her share her biomedical research training and experience with the Chinese scientific community and increase her international exposure. She looks forward to this new challenge and hopes to develop greater leadership skills and gain a deeper understanding of conducting clinical research and development in emerging markets.
The United States Centers for Disease Control and Prevention (U.S. CDC) collaborates with the Chinese Center for Disease Control and Prevention (China CDC) on research and surveillance for invasive pneumococcal and other diseases in China.